David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Illinois Tool Works
ITW
$80.4B
| $123M | 0.07% |
501,187
+444,971
| +792% | +$111M |
|
327
Globant
GLOB
$1.71B
| $123M | 0.07% |
1,881,661
-249,985
| -12% | -$15.7M |
|
328
PUT
JD.com
JD
$39.7B
| $123M | 0.07% |
4,284,400
+551,200
| +15% | +$17.2M |
|
329
PUT
Alphabet (Google) Class C
GOOG
$4.18T
| $122M | 0.07% |
388,000
-344,900
| -47% | -$98.8M |
|
330
Cencora
COR
$60.7B
| $121M | 0.07% |
359,131
+128,769
| +56% | +$43.9M |
|
331
Zebra Technologies
ZBRA
$17.4B
| $121M | 0.07% |
499,387
+428,245
| +602% | +$115M |
|
332
PUT
Moderna
MRNA
$57.9B
| $121M | 0.07% |
4,111,100
-223,600
| -5% | -$6.07M |
|
333
CALL
Royal Bank of Canada
RY
$285B
| $121M | 0.07% |
709,700
+175,000
| +33% | +$26.9M |
|
334
Regeneron Pharmaceuticals
REGN
$85.9B
| $120M | 0.07% |
155,475
-706,118
| -82% | -$480M |
|
335
Citigroup
C
$221B
| $119M | 0.07% |
1,023,564
-1,876,280
| -65% | -$195M |
|
336
Icon
ICLR
$13.3B
| $119M | 0.07% |
653,319
-823,782
| -56% | -$147M |
|
337
Planet Fitness
PLNT
$4.09B
| $119M | 0.07% |
1,097,317
+1,094,776
| +43,084% | +$113M |
|
338
PUT
American Airlines Group
AAL
$9.15B
| $119M | 0.07% |
7,763,100
-653,400
| -8% | -$8.81M |
|
339
PUT
ASML
ASML
$677B
| $119M | 0.07% |
111,000
-105,300
| -49% | -$110M |
|
340
Fluence Energy
FLNC
$1.62B
| $119M | 0.07% |
5,991,898
+4,479,424
| +296% | +$84.4M |
|
341
Corebridge Financial
CRBG
$14.2B
| $117M | 0.06% |
3,886,423
-115,287
| -3% | -$3.54M |
|
342
Humana
HUM
$45.5B
| $116M | 0.06% |
453,472
-230,224
| -34% | -$60.4M |
|
343
Bath & Body Works
BBWI
$3.92B
| $116M | 0.06% |
5,769,235
+4,844,144
| +524% | +$107M |
|
344
PUT
PayPal
PYPL
$52.7B
| $115M | 0.06% |
1,968,300
-868,100
| -31% | -$56.4M |
|
345
ExxonMobil
XOM
$679B
| $114M | 0.06% |
945,737
-290,804
| -24% | -$33.7M |
|
346
DuPont de Nemours
DD
$18.7B
| $113M | 0.06% |
938,631
-4,354,027
| -82% | -$490M |
|
347
Lam Research
LRCX
$393B
| $112M | 0.06% |
656,672
+115,955
| +21% | +$18M |
|
348
Inspire Medical Systems
INSP
$1.8B
| $112M | 0.06% |
1,212,162
+853,305
| +238% | +$81.6M |
|
349
Halozyme
HALO
$12.3B
| $111M | 0.06% |
1,649,466
-1,000,909
| -38% | -$67.3M |
|
350
Paylocity
PCTY
$8.14B
| $110M | 0.06% |
722,746
+127,860
| +21% | +$19M |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.